Tolerability and efficacy of paliperidone ER compared to olanzapine in the treatment of schizophrenia: A randomized, double-blind, multicentric trial
Background: Paliperidone is an active metabolite of risperidone and actss through a combination of central dopamine Type 2 (D2) and serotonin Type 2 (5HT2A) receptor antagonism. Aim: The present randomized, double-blind, multicentric trial was designed to determine the safety and efficacy of paliper...
Main Authors: | Sandip Shah, Dipti Joshi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | Industrial Psychiatry Journal |
Subjects: | |
Online Access: | http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2011;volume=20;issue=1;spage=25;epage=31;aulast=Shah |
Similar Items
-
Paliperidon palmitata bağlı siyalore
by: Cengiz Cengisiz, et al.
Published: (2016-12-01) -
Paliperidone palmitate-induced enuresis: a case report
by: S. Cruz, et al.
Published: (2022-06-01) -
Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability
by: Gattaz WF, et al.
Published: (2020-09-01) -
Drug utilization of paliperidone in adolescent schizophrenia patients: A retrospective cohort study in China
by: S. Dong, et al.
Published: (2021-04-01) -
Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based review
by: Emsley R, et al.
Published: (2018-01-01)